Semba Charles Pauling — SEC Form 4 filings

SEC reporting owner CIK 1872863. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-03.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-06-03 to 2026-06-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
DiaMedica Therapeutics Inc. (DMAC)Director55

Form 4 filings — Semba Charles Pauling

FiledFormIssuerReported transactionsSource
2026-06-034DiaMedica Therapeutics Inc. (DMAC)Grant/award (A): 40,412 (derivative) @ $0EDGAR
2026-01-064DiaMedica Therapeutics Inc. (DMAC)Grant/award (A): 3,355 @ $8.42EDGAR
2025-06-034DiaMedica Therapeutics Inc. (DMAC)Grant/award (A): 32,162 (derivative) @ $0EDGAR
2025-01-034DiaMedica Therapeutics Inc. (DMAC)Grant/award (A): 5,290 @ $5.34EDGAR
2024-06-034DiaMedica Therapeutics Inc. (DMAC)Grant/award (A): 28,472 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1872863 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →